Cécile Thomas de La Pintière

DNAX accessory molecule‐1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vγ9Vδ2 T cells

Olivier Toutirais, Florian Cabillic, Gaëlle Le Friec et al. · European Journal of Immunology · 2009 · 122 citations

Dnax Accessory Molecule‐1, Immunology, Immunologic Mechanism +16

Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas

Françoise Bouet-Toussaint, Florian Cabillic, Olivier Toutirais et al. · Cancer Immunology Immunotherapy · 2007 · 104 citations · Full text

Human Solid Tumors, Cancer Immunosurveillance, Immunology +9

Aminobisphosphonate-pretreated dendritic cells trigger successful Vγ9Vδ2 T cell amplification for immunotherapy in advanced cancer patients

Florian Cabillic, Olivier Toutirais, Vincent Lavoué et al. · Cancer Immunology Immunotherapy · 2010 · 68 citations · Full text

Cancer Immunosurveillance, Advanced Cancer Patients, Immunology +10

HLA-A*0201-restricted CEA-derived Peptide CAP1 Is Not a Suitable Target for T-cell-based Immunotherapy

Émilie Fauquembergue, Olivier Toutirais, David Tougeron et al. · Journal of Immunotherapy · 2010 · 17 citations

T-cell-based Immunotherapy, Immunology, Immunoediting +19

Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: Implications for immunotherapy

Vincent Lavoué, Florian Cabillic, Olivier Toutirais et al. · International Journal of Cancer · 2011 · 16 citations · Full text

Lymphocyte Development, Epithelial Ovarian Cancer, Immunology +22